Avidity Biosciences (RNA) Leases: 2020-2025
Historic Leases for Avidity Biosciences (RNA) over the last 6 years, with Sep 2025 value amounting to $52.8 million.
- Avidity Biosciences' Leases rose 738.99% to $52.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.8 million, marking a year-over-year increase of 738.99%. This contributed to the annual value of $5.6 million for FY2024, which is 32.06% down from last year.
- According to the latest figures from Q3 2025, Avidity Biosciences' Leases is $52.8 million, which was up 1,150.25% from $4.2 million recorded in Q2 2025.
- In the past 5 years, Avidity Biosciences' Leases registered a high of $52.8 million during Q3 2025, and its lowest value of $45,000 during Q3 2021.
- Over the past 3 years, Avidity Biosciences' median Leases value was $7.6 million (recorded in 2024), while the average stood at $11.1 million.
- Per our database at Business Quant, Avidity Biosciences' Leases slumped by 87.94% in 2021 and then soared by 20,486.67% in 2022.
- Over the past 5 years, Avidity Biosciences' Leases (Quarterly) stood at $10.8 million in 2021, then declined by 18.81% to $8.8 million in 2022, then decreased by 5.53% to $8.3 million in 2023, then tumbled by 32.06% to $5.6 million in 2024, then skyrocketed by 738.99% to $52.8 million in 2025.
- Its last three reported values are $52.8 million in Q3 2025, $4.2 million for Q2 2025, and $4.9 million during Q1 2025.